FDA Drug Application (017001) for ANCOBON by VALEANT

Back to FDA Applications sponsored by VALEANT

Application Number017001
Product Number001
FormCAPSULE;ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameANCOBON
Active IngredientFLUCYTOSINE

Active IngredientCount
List of drugs with Active Ingredient FLUCYTOSINE2


Back to FDA Applications sponsored by VALEANT